US Patent Issued to BEIJING TIDE PHARMACEUTICAL on Aug. 11 for "Method for treating graft versus host disease caused by hematopoietic stem cell transplantation" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,668, issued on Aug. 11, was assigned to BEIJING TIDE PHARMACEUTICAL Co. LTD. (Beijing).

"Method for treating graft versus host disease caused by hematopoietic stem cell transplantation" was invented by Cheung Ling Cheng (Beijing), Yanping Zhao (Beijing), Hongjun Wang (Beijing), Weiting Zhong (Beijing), Jing Li (Beijing), Jing Zhao (Beijing) and Weina Liu (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for preventing, alleviating and/or treating graft versus host disease caused by hematopoietic stem cell transplantation, which comprises administering an effective amount of a compound of formula (I), or a pharmaceutically acceptable s...